ANI ‘On The Cusp Of A Transformation’ Following Cortrophin Launch

Company Expects Up To $40m From The Product In 2022

Close up of ANI sign at their Canadian head office in Oakville
ANI's share price took a hit following losses related to commercial expenses. • Source: Shutterstock

More from Earnings

More from Business